|Videos|July 26, 2022
Fezolinetant making waves for VMS
Author(s)Morgan Ebert
Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Third trimester cervical length could help identify women at risk of spontaneous preterm birth
2
Saffron extract linked to mood and sleep gains in menopausal women
3
Psychological and urogenital menopause symptoms similarly burdensome regardless of age at menopause onset
4
Kate McLean, MD, MPH, FACOG: Better understanding bacterial vaginosis
5